References: Acute bacterial prostatitis

Australian Commission on Safety and Quality in Health Care (ACSQHC). AURA 2023: Fifth Australian report on antimicrobial use and resistance in human health. Sydney: Australian Commission on Safety and Quality in Health Care (ACSQHC),; 2023. Updated 16 Nov 2023. Accessed 16 Nov 2023. https://www.safetyandquality.gov.au/our-work/antimicrobial-resistance/antimicrobial-use-and-resistance-australia-aura/aura-2023-fifth-australian-report-antimicrobial-use-and-resistance-human-health
Australian Group on Antimicrobial Resistance (AGAR). Australian Gram-negative Surveillance Outcome Program (GnSOP) Bloodstream Infection Annual Report 2023. 2024. https://agargroup.org.au/agar-reports/
Bonkat G, Bartoletti R, Bruyère F, Cai T, Geerlings SE, Köves B, et al. EAU Guidelines on Urological Infections. Arnhem, NL: European Association of Urology; 2024. https://uroweb.org/guidelines/urological-infections
Charalabopoulos K, Karachalios G, Baltogiannis D, Charalabopoulos A, Giannakopoulos X, Sofikitis N. Penetration of antimicrobial agents into the prostate. Chemotherapy 2003;49(6):269-79. https://www.ncbi.nlm.nih.gov/pubmed/14671426
Gill BC, Shoskes DA. Bacterial prostatitis. Curr Opin Infect Dis 2016;29(1):86-91. https://pubmed.ncbi.nlm.nih.gov/26555038/
Karaiskos I, Galani L, Sakka V, Gkoufa A, Sopilidis O, Chalikopoulos D, et al. Oral fosfomycin for the treatment of chronic bacterial prostatitis. J Antimicrob Chemother 2019;74(5):1430-7. https://www.ncbi.nlm.nih.gov/pubmed/30796442
Lam JC, Lang R, Stokes W. How I manage bacterial prostatitis. Clin Microbiol Infect 2023;29(1):32-7. https://www.ncbi.nlm.nih.gov/pubmed/35709903
Miller AC, Arakkal AT, Sewell DK, Segre AM, Tholany J, Polgreen PM, et al. Comparison of Different Antibiotics and the Risk for Community-Associated Clostridioides difficile Infection: A Case-Control Study. Open Forum Infect Dis 2023;10(8):ofad413. https://www.ncbi.nlm.nih.gov/pubmed/37622034
National Institute for Clinical Excellence (NICE). Prostatitis (acute): antimicrobial prescribing. National Institute for Clinical Excellence (NICE); 2018. https://www.nice.org.uk/guidance/ng110
Nelson Z, Tarik Aslan A, Beahm NP, Blyth M, Cappiello M, Casaus D, et al. Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus Statement. JAMA Netw Open 2024;7(11):e2444495. https://www.ncbi.nlm.nih.gov/pubmed/39495518
Slimings C, Riley TV. Antibiotics and healthcare facility-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update. J Antimicrob Chemother 2021;76(7):1676-88. https://www.ncbi.nlm.nih.gov/pubmed/33787887
Yebes A, Toribio-Vazquez C, Martinez-Perez S, Quesada-Olarte JM, Rodriguez-Serrano A, Alvarez-Maestro M, et al. Prostatitis: A Review. Curr Urol Rep 2023;24(5):241-51. https://www.ncbi.nlm.nih.gov/pubmed/36881349
Zohar I, Maor Y. Shirin, N. Yahav, D. Current management strategies for multidrug-resistant Gram-negative urinary tract infections, a focus on aminoglycosides monotherapy. Elsevier 2024;1(2). https://www.sciencedirect.com/science/article/pii/S295059092405039X